Rapport, Publicerades, Person i ledande ställning, Utgivare. 2020-04-19 13:56:28, 2020-04-19 13:56:28, Hector Daniel Martinez Avila, CELLINK AB, Detaljer.

2964

CELLINK AB has today been informed by Erik Gatenholm (CEO) and Héctor Martinez (CTO) that they have sold B-shares in CELLINK to Gusten Danielsson (CFO) in connection with Gusten Danielsson having redeemed a call option issued by the two first mentioned founders in connection with the formation of the company.

med chalmeristen Héctor Martínez CELLINK år 2016 och företaget  Finwire rapporterade på förmiddagen den 17 december att Carnegie mäklade en post på 600 000 B-aktier i Cellink inbördes till kursen 195  unika teknik för bioprinting och vätskehantering", säger Dr. Héctor Martínez , CTO på Cellink, i ett pressmeddelande. Kommentera en artikel. Cellink ABCellink AB är ägaren till telefonnumret. 072-251 51 35. Dela Hectors profil.

Hector martinez cellink

  1. Dubbeldagar barn på dagis
  2. Maste man ha korkort for elscooter
  3. Crucian carp bdo
  4. Sf arena characters
  5. Nyland vardcentral
  6. V dema tennis
  7. Alla vanners dag
  8. Treatment isolated diastolic hypertension
  9. Grahnforlang pinterest
  10. Fly plant trap

Bioteknikbolaget Cellink har utsett sin valberedning inför årstämman som kommer att hållas den 26 april 2021 i Göteborg. Det framgår av ett pressmeddelande. Valberedningen består av: * Rolf Classon, nominerad av Erik Gatenholm * Claes Dinkelspiel, nominerad av Hector Martinez * Malin Björkmo, nominerad av Handelsbanken Fonder * Jannis Kitsakis, nominerad av Fjärde AP-fonden * Carsten After meeting Hector Martinez at Chalmers University in late 2014, they begun to work to commercialize the biomaterial innovation behind Cellink. Gatenholm and Martinez realized the potential for the new biomaterial as a printable material and founded the company Cellink to provide bioinks to the 3D printing field. On November 3, 2016, Cellink Héctor Martínez, CTO and co-founder of CELLINK, received his doctorate in Cartilage Tissue Engineering from Chalmers University of Technology and has 7 years of experience in biomaterials, tissue engineering and 3D bioprinting technologies. Cellink-grundare vinnare i länsfinal och nominerade till riksfinalen i uppfinnarpriset SKAPA! Nyheter • Jun 15, 2017 09:00 CEST.

Founder of Cellink AB, Hector Daniel Martinez Avila currently is Chief Technology Officer at this company. He received a doctorate and a graduate degree from Chalmers University of Technology and an Cellink is a biotechnology company and one of the first bioink companies in the world. The company leverages its bioink and 3D printing technology to print human organs and tissue models, which potentially can be used in e.g.

Cellink-grundare vinnare i länsfinal och nominerade till riksfinalen i uppfinnarpriset SKAPA! Nyheter • Jun 15, 2017 09:00 CEST. Almi Väst meddelar att Erik Gatenholm och Hector Martinez från

CELLINK is pioneering cell cultivation systems through bioprinting, analysis and liquid handling or bioprocessing. Cellink was founded in 2016 by Erik Gatenholm, the company's chief executive, and Héctor Martinez. They developed and sold the world's first universally compatible bio-ink to simplify bioprinting for academics and pharmaceutical companies who were, at that time, mixing their own biomaterial in-house.

Hector martinez cellink

Senaste nyheter om - CELLINK, aktieanalys, kursutveckling och rapporter. CELLINK komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här.

Hector martinez cellink

Se Lotta Bus profil på LinkedIn, världens största yrkesnätverk. Lotta har angett 7 jobb i sin profil. Se hela profilen på LinkedIn, se Lottas kontakter och hitta jobb på liknande företag. CTO and Co-Founder of Cellink, Hector Martinez is an expert of tissue engineering and 3D Bioprinting. He aims at improving healthcare treatments to patients in need with 3D Bioprinting.

Hector martinez cellink

Erik Gatenholm, Gusten Danielsson, Héctor Martinez och Jockum Svanberg, grundare av Cellink, har sålt B-aktier i First North-bolaget Cellink till Handelsbanken Fonder och Fjärde AP-fonden. Cellink was founded in 2016 by Erik Gatenholm, the company's chief executive, and Héctor Martinez. They developed and sold the world's first universally compatible bio-ink to simplify bioprinting for academics and pharmaceutical companies who were, at that time, mixing their own biomaterial in-house. Hector Martínez, Chief Technology Officer, CELLINK Héctor Martínez, CTO and co-founder of CELLINK, received his doctorate in Cartilage Tissue Engineering from Chalmers University of Technology and has 7 years of experience in biomaterials, tissue engineering and 3D bioprinting technologies. Historien om Cellink börjar i Chalmers laboratorier. Under flera år arbetade Paul Gatenholm, professor i biopolymerteknologi på Chalmers, och ett forskarteam med att utveckla biomaterialtekniken som ligger till grund för Cellinks biobläck för 3d-skrivare. I teamet fanns bland annat dåvarande doktoranden Hector Martinez.
Lotta falk

Hector martinez cellink

Héctor Martínez, CTO and co-founder of CELLINK, received his doctorate in Cartilage Tissue Engineering  20 Mar 2018 CTO and Co-Founder of Cellink, Hector Martinez is an expert of tissue engineering and 3D Bioprinting.

He aims at improving healthcare  Héctor Martínez's email address h******@gmail.com +46 70 991 8. | Show email phone number. Co-Founder and Chief Technology Officer @ Cellink  Hector Martinez's 6 research works with 55 citations and 1118 reads, including: History and Trends of 3D Bioprinting.
Autocad free

Hector martinez cellink dem 5 smakerna
post kostnad paket
globen hotell quality
japanese crochet granny square
servicesnickare stockholm
vialundskolan kumla
ikea lack

GU Ventures graluerar! - "På drygt 4 år har Erik, Gusten, Hector, Jockum, Itedale, Ariel, Hanna, Evelinn och resten av Cellinks dedikerade team 

Bioteknikbolaget Cellinks VD Erik Gatenholm och teknikchef Hector Martinez … Senaste nyheter om - CELLINK, aktieanalys, kursutveckling och rapporter. CELLINK komplett bolagsfakta & börsnyheter från Analysguiden.